News Ningbo Shuangcheng Passes U . S . FDA Inspection 2019.12.05 Ningbo Shuangcheng Pharmaceuticals Ltd (NBSP) has received the unannounced on-site inspection by the U.S. FDA from 14 October to 18 Octo...
Contact
Tel: 0+86-898-6855-7717
Fax: +86-898-6865-2226
Email: vivian. chen@hnsp.com
News
-
Ningbo Shuangcheng Passes U.S. FDA Inspection -
Hainan Shuangcheng Passes U.S. FDA Inspection
Hainan Shuangcheng Passes U.S. FDA Inspection 2016.01.29 From 25~28 January, Hainan Shuangcheng has received the unannounced inspection of the US FDA regarding the API Workshop. One of the US FDA inves...
-
Bivalirudin for Injection Receives U.S. FDA Final Approval
On 23 October 2019, Hainan Shuangcheng Pharmaceuticals Co. Ltd (the company) received the notification from the U.S. Food and Drug Administration (FDA) that the ANDA (abbreviated new drug application) ...
-
Shuangcheng Donates Medical Products to Support Fighting of COVID-19
Facing the severe situation of fighting against COVID-19, Hainan Shuangcheng Pharmaceuticals Co., Ltd (the company) pays close attention to the spread of the epidemic, performs its own role well in epi...
-
Bivalirudin for Injection First Launched in U.S.
On 17 March 2020 , Hainan Shuangcheng Pharmaceuticals Co. Ltd (the company) first launched Bivalirudin for Injection in the United States . On the morning of March 17, the company held a U . S . launch...
